Literature DB >> 23472968

HMGA1 overexpression correlates with relapse in childhood B-lineage acute lymphoblastic leukemia.

Sujayita Roy1, Francescopaolo Di Cello, Jeanne Kowalski, Alexandra C Hristov, Hua-Ling Tsai, Deepa Bhojwani, Julia A Meyer, William L Carroll, Amy Belton, Linda M S Resar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23472968      PMCID： PMC5036165          DOI： 10.3109/10428194.2013.782610

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  17 in total

1.  Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.

Authors:  Stefan Nagel; Michaela Scherr; Alexander Kel; Klaus Hornischer; Gregory E Crawford; Maren Kaufmann; Corinna Meyer; Hans G Drexler; Roderick A F MacLeod
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

2.  Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies.

Authors:  Laura E Hogan; Julia A Meyer; Jun Yang; Jinhua Wang; Nicholas Wong; Wenjian Yang; Gregory Condos; Stephen P Hunger; Elizabeth Raetz; Richard Saffery; Mary V Relling; Deepa Bhojwani; Debra J Morrison; William L Carroll
Journal:  Blood       Date:  2011-09-14       Impact factor: 22.113

3.  Flavopiridol induces BCL-2 expression and represses oncogenic transcription factors in leukemic blasts from adults with refractory acute myeloid leukemia.

Authors:  Dwella M Nelson; Biju Joseph; Joelle Hillion; Jodi Segal; Judith E Karp; Linda M S Resar
Journal:  Leuk Lymphoma       Date:  2011-07-05

4.  Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations.

Authors:  Anna Andersson; Tor Olofsson; David Lindgren; Björn Nilsson; Cecilia Ritz; Patrik Edén; Carin Lassen; Johan Råde; Magnus Fontes; Helena Mörse; Jesper Heldrup; Mikael Behrendtz; Felix Mitelman; Mattias Höglund; Bertil Johansson; Thoas Fioretos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-14       Impact factor: 11.205

5.  Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group.

Authors:  Torsten Haferlach; Alexander Kohlmann; Lothar Wieczorek; Giuseppe Basso; Geertruy Te Kronnie; Marie-Christine Béné; John De Vos; Jesus M Hernández; Wolf-Karsten Hofmann; Ken I Mills; Amanda Gilkes; Sabina Chiaretti; Sheila A Shurtleff; Thomas J Kipps; Laura Z Rassenti; Allen E Yeoh; Peter R Papenhausen; Wei-Min Liu; P Mickey Williams; Robin Foà
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

6.  The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?

Authors:  Joelle Hillion; Surajit Dhara; Takita Felder Sumter; Mita Mukherjee; Francescopaolo Di Cello; Amy Belton; James Turkson; Souyma Jaganathan; Linzhao Cheng; Zhaohui Ye; Richard Jove; Peter Aplan; Ying-Wei Lin; Kelsey Wertzler; Ray Reeves; Ossama Elbahlouh; Jeanne Kowalski; Raka Bhattacharya; Linda M S Resar
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 7.  Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.

Authors:  Stephen P Hunger; Mignon L Loh; James A Whitlock; Naomi J Winick; William L Carroll; Meenakshi Devidas; Elizabeth A Raetz
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

8.  Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells.

Authors:  Tim C P Somervaille; Christina J Matheny; Gary J Spencer; Masayuki Iwasaki; John L Rinn; Daniela M Witten; Howard Y Chang; Sheila A Shurtleff; James R Downing; Michael L Cleary
Journal:  Cell Stem Cell       Date:  2009-02-06       Impact factor: 24.633

9.  HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks.

Authors:  Sandeep N Shah; Candace Kerr; Leslie Cope; Elias Zambidis; Cyndi Liu; Joelle Hillion; Amy Belton; David L Huso; Linda M S Resar
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

10.  HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.

Authors:  Amy Belton; Alexander Gabrovsky; Young Kyung Bae; Ray Reeves; Christine Iacobuzio-Donahue; David L Huso; Linda M S Resar
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240
View more
  18 in total

Review 1.  The high mobility group A1 molecular switch: turning on cancer - can we turn it off?

Authors:  Tait H Huso; Linda M S Resar
Journal:  Expert Opin Ther Targets       Date:  2014-03-31       Impact factor: 6.902

2.  Hitting the bull's eye: targeting HMGA1 in cancer stem cells.

Authors:  Breann L Yanagisawa; Linda M S Resar
Journal:  Expert Rev Anticancer Ther       Date:  2014-01       Impact factor: 4.512

Review 3.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

4.  Nanoparticle delivery of inhibitory signal transducer and activator of transcription 3 G-quartet oligonucleotides blocks tumor growth in HMGA1 transgenic model of T-cell leukemia.

Authors:  Joelle Hillion; Amy M Belton; Sandeep N Shah; James Turkson; Naijie Jing; David J Tweardy; Francescopaolo di Cello; David L Huso; Linda M S Resar
Journal:  Leuk Lymphoma       Date:  2013-08-13

5.  STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway.

Authors:  Amy Belton; Lingling Xian; Tait Huso; Michael Koo; Li Z Luo; James Turkson; Brent D G Page; Patrick T Gunning; Guosheng Liu; David L Huso; Linda M S Resar
Journal:  Leuk Lymphoma       Date:  2016-03-08

Review 6.  The biology of relapsed acute lymphoblastic leukemia: opportunities for therapeutic interventions.

Authors:  Teena Bhatla; Courtney L Jones; Julia A Meyer; Nicholas A Vitanza; Elizabeth A Raetz; William L Carroll
Journal:  J Pediatr Hematol Oncol       Date:  2014-08       Impact factor: 1.289

Review 7.  Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.

Authors:  Linda Resar; Lionel Chia; Lingling Xian
Journal:  Cancer Res       Date:  2018-04-04       Impact factor: 12.701

8.  The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.

Authors:  Joelle Hillion; Sujayita Roy; Mohammad Heydarian; Leslie Cope; Lingling Xian; Michael Koo; Li Z Luo; Kathleen Kellyn; Brigitte M Ronnett; Tait Huso; Deborah Armstrong; Karen Reddy; David L Huso; L M S Resar
Journal:  Gynecol Oncol       Date:  2016-04-08       Impact factor: 5.482

9.  High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.

Authors:  Mikhail Gorbounov; Neil M Carleton; Rebecca J Asch-Kendrick; Lingling Xian; Lisa Rooper; Lionel Chia; Ashley Cimino-Mathews; Leslie Cope; Alan Meeker; Vered Stearns; Robert W Veltri; Young Kyung Bae; Linda M S Resar
Journal:  Breast Cancer Res Treat       Date:  2019-09-17       Impact factor: 4.624

Review 10.  Critical role of the high mobility group A proteins in hematological malignancies.

Authors:  Marco De Martino; Francesco Esposito; Alfredo Fusco
Journal:  Hematol Oncol       Date:  2021-10-12       Impact factor: 4.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.